Great investor briefing, and the best part is, even this far into phase 3 we still have no
Side effects, what a blessing for the patients and a huge bonus for Dimerix
to still be able to say, our treatment for FSGS has no SIDE EFFECTS !
Not every company trying to treat FSGS can say this, but we sure as heck can.
I think one resident pest will get the message when he reads this lol
Ann: Dimerix to present at Melbourne Twilight Investor Briefing, page-8
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
56.5¢ |
Change
0.015(2.73%) |
Mkt cap ! $339.0M | |||
| Open | High | Low | Value | Volume |
| 56.0¢ | 57.5¢ | 55.5¢ | $1.770M | 3.142M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 70978 | 56.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 57.0¢ | 38029 | 2 |
View Market Depth
| Last trade - 15.56pm 25/07/2025 (20 minute delay) ? |
| DXB (ASX) Chart |